Soft Tissue, Joint, and Bone disorders Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Marfan syndrome: pathogenesis

A
  • causes fragility of stretching tissues such as aorta
  • genetic defect on proteins associated with elasin (important for maintaining extensibility)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Marfan syndrome: clinical presentation

A
  • lanky person (long fingers, limbs etc)
  • silent killer effects blood vessels and aorta
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Marfan syndrome: risk factors

A

risk is with parent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ehlers Danlos Syndrome: pathogenesis

A
  • genetic
  • variants in specific genes that provide instructions for making collagen and related proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ehlers Danlos Syndrome: risk factors

A
  • parents have it
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ehlers Danlos Syndrome: clincal presenation

A
  • joint laxity of capsule and other tissues
  • joint pain, hypermobility, subluxations
  • uterine and skin over stretchable,
  • can attack vessels
  • disabling musculoskeletal pain and scoliosis
  • joint instability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hypertropic ossification: general/myositis ossifcans, and neurogenic HO

A
  • bone growth in nonosseous tissue or soft tissue
  • myositis ossifcans: specific to muscle
  • neurogenic HO: nervous tissue impairments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hypertropic ossification risk factors

A
  • traumatic injury
  • previous h/o
  • hypertrophic osteoarthritis
  • ankylosing spondylitis
  • diffuse idiopathic skeletal hyperostosis
  • surgery
  • burns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hypertropic ossification pathogenesis

A
  • pluripotent mesenchymal cells
  • mechanical stress
  • systemic factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hypertropic ossification clincal manifestation

A
  • progressive unexpected loss of ROM
  • often within 2 weeks of injury
  • inflammation
  • over 3-5 months there is a hard end feel
  • pain
  • causing to stop moving
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hypertropic ossification management

A
  • prevention (radiation, NSAIDs, diphophonates)
  • controlling hemoatoma, RICE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Rhabdomylosis overview

A
  • breakdown of skeletal muscle
  • release of creatine phosphokinase enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Rhabdomylosis risk factors

A
  • strenuous activity
  • side effects from statins
  • linked to some herbal supplements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Rhabdomylosis pathogenesis

A
  • skeletal muscle breaks down
  • acute renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rhabdomylosis clincal manifestations

A
  • fatigue
  • myalgia
  • myoglobinuria (cola colored urine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rhabdomylosis management

A
  • lab results: abnormal renal fct and elevated creatine phosphokinase
  • re-hydration, dialysis
  • usually reversible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Myofascial Pain syndrome and Trigger points: risk factors

A
  • stress, injruy
  • overuse/overload
  • viseral pain and dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Myofascial Pain syndrome and Trigger points: pathogenesis

A
  • excessive ACh
  • inhibition of AChE
  • integrated TrP hypothesis
  • decreased pH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Myofascial Pain syndrome and Trigger points clincial manifestations

A
  • taut band in affected muscle
  • trigger points in muscle
  • referred pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Myofascial Pain syndrome and Trigger points: management

A
  • good history and evaluation
  • look for structural or mechanical factors
  • metabolic and hormonal mgt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Myopathy hereditary causes

A
  • muscular dystrophy
  • congenital myopathy
  • myotonia
  • metabolic myopathy
  • mitochondrial myopathy
  • neurologic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

acquired myopathy

A
  • inflammatory myopathy
  • endocrine myopathy
  • systemic illness myopathy
  • drug induced (stain)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Joint Disorders

A
  • Osteoarthritis
  • ## Degenerative Inter vertebral Disk Disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Osteoarthritis overview

A
  • early joint space widening
  • subchondral bone sclerosis
  • subchondral bone cysts
  • osteophytes (out growths of bone)
  • Joint Space narrowing (once inflammation goes away)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Pathogenesis of osteoarthritis

A
  • synovial inflammation
  • loss of hyaline cartilage
  • hypertrophic changes in bone and joint capsule
  • focal calcifications of the cartilage
  • joint space narrows
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Risk factors of osteoarthritis

A
  • genetic association influenced by environmental/nutrition
  • Participation in particular sports of occupations
  • joint laxity
  • connective tissue damage or disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

osteoarthritis: radio graphic Findings (clinical Manifestations)

A
  • Joint space widening
  • subchondral bone sclerosis
  • subchondral bone cysts
  • osteophytes
  • joint space narrowing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

American College of Rheumatology: osteoarthritis

A

knee pain with 3 of the following
1. older than 50
2. morning stiffness less than 30 minutes or crepitus with motion
3. bony tenderness
4. bony enlargement
5. no palpable warmth over knee

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Clinical manifestations: osteoarthritis

A
  • bony enlargement
  • limited ROM
  • crepitus on motion
  • tenderness on pressure
  • joint effusion
  • malalignment
  • joint deformity
  • weight bearing joints usually
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

OA in IP joints of the fingers

A
  • Bouchards Nodes = PIP
  • Herberdens Nodes = DIP joints
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

OA: PT implications

A
  • symptoms may not equate with radiographic findings
  • POC based on clinical exam
  • side effect of OA meds: NSAIDs, corticosteriods
  • Joint protection
  • interventions: less WB
32
Q

Degenerative Disk Disease (DDD): Overview

A
  • degeneration at intervertebral disk articulations
  • no consensus on definition
  • begins early in life visble by age 30
  • > 1/2 of all Americans > 40 yrs have some type of DDD
33
Q

DDD risk factors

A
  • familial aggregation (some genes are identified)
  • excessive forces
  • potential risk factors: Psychosocial, smoking, height, atherosclerosis
34
Q

Pathogenesis: DDD

A
  • impaired cellular nutrition (compressive forces can cause this and loss of fluid)
  • reduced cellular viability
  • cellular senescence: cells/fibroblasts die
  • accumulation of degraded matrix macromolecules (scar tissue)
  • fatigue failure of the matrix
  • there are 3 stages
35
Q

DDD implications for PT

A
  • spinal stenosis often occurs with DDD (they will want to avoid extension)
  • exercise: careful assessment, abdominal strengthening, postural training, increased flexibility, aerobic conditioning
36
Q

Bone disorders:

A
  • Fracture
37
Q

4 categories of fractures?

A
  • sudden impact
  • stress or fatigue
  • insufficiency fracture (pathological in bones such as osteopenia, osteoporosis, Ca metabolism disorders)
  • Pathological fracture
38
Q

Fracture orientation types (describe + look at picture)

A
  1. transverse:
  2. oblique
  3. spiral
  4. comminuted
  5. Segmental
  6. Butterfly
39
Q

Patellar Fx

A
  • undisplaced
  • transverse
  • lower or upper pole
  • multifragmented (displaced vs non displaced)
  • Vertical
  • osteochondral
40
Q

FX: healing process

A
  1. hematoma formation: 48-72 hours after fx, clotting factors are initiated
  2. Cellular proliferation: osteogenic cells proliferate forming a fibrocartilage collar
  3. callous formation: collars unite and osteoblasts move to site
  4. ossification: bone replaces cartilage
  5. consolidation: excess bone is reabsorbed and remodelled based on mechanical stress
41
Q

Chondrolysis: overview

A
  • progressive cartilage degeneration
  • most often result of slipped capital femoral epiphysis (femoral head growth plate slips from the rest of the bone)
  • can result from infection, trauma, prolonged immobilization
42
Q

Chondrolysis: etiology-unkwown

A
  • theories suggest nutrition, mechanical, ischemia, abnormal chondrocyte metabolism, abnormal intracapsular pressure
43
Q

Clincal manifestations: Chondrolysis

A
  • progressive joint stiffness with loss of motion and pain
44
Q

medical management: Chondrolysis

A
  • imaging
  • NSAIDs, protective wt bearing, surgery
45
Q

Osteochondroses: overview

A
  • disorders of the epiphyses of growing children
  • common thread = avascular necrosis (no blood supply to the bone/cartilage) causing cell death
  • AKA epiphysitis, osteochondritis, aaseptic necrosis, ischemic, epiphyseal necrosis
46
Q

Examples of Osteochondroses

A
  1. kohler disease: fracture of navicular bone will normally affect growth plate and cut off blood supply
  2. Osgood-Schlatter Disease: bones grow and muscle don’t stretch
  3. Legg-Calve-Perthes Disease
47
Q

Osteochondritis Dissecans

A
  • localized subchondral necrosis followed by recalcification
  • a piece of articular cartilage and a fragment of bone separate and pull away from the bone
  • can end up with loose bodies in the joint causing stiffness/locking
  • most common at concave surfaces of synovial joints (medial femoral head, talar head, capitulum of humerus)
  • repetitive microtrauma causes ischemia and disrupts subchondral growth
  • Wilson sign: pain with knee extension and tibial IR and relieved with Tibia ER
48
Q

Osteonecrosis

A
  • AKA avascular necrosis and aseptic necrosis
  • death of bone and bone marrow due to loss of blood supply in absence of infection
  • ## femoral head most common sit: chandler disease
49
Q

Legg-Calve-Perthes disease

A
  • affects femur
  • blood spully to the femoral head is disrupted
  • causes a flattened head
  • femur does not sit correctly
  • pain stiffness, loss of ROM
50
Q

Pathophysiology of Legg-Calve-Perthes disease: stages of recovery

A
  • Avascular stage 1-2 weeks
  • revascularization/fragmentation stage 6-12 months
  • reparative stage 2-3 years
  • regenerative stage: final months
51
Q

Osgood-Schlatter Disease: Pathophysiolgy

A
  • Fibers of patellar tendon pull small pieces of immature bone from tibial tuberosity
  • tendonitis/tendonsis of patellar ligament
52
Q

Osgood-Schlatter Disease: risk factors

A
  • abnormal alignment
  • repetitive stress
  • indirect trauma
  • active adolescent (more common in boys 8-15 yrs; girls 8-13)
53
Q

Osgood-Schlatter Disease: clinical manifestations

A
  • aching pain at tibial tuberosity
  • aggravated by active knee extension or resisted knee flexion
  • often tight hamstrings, IT band, Triceps surae, quadriceps
  • can use a strap to compress and keep tendon in place
54
Q

Osgood-Schlatter Disease: PT implications

A
  • immobilization is not recommended
  • rest modification
  • time allowed for revascularization, healing, ossification
  • exercises to improve mechanical inefficiencies (stretching/strengthen)
  • Balance/coordination
  • knee sleeve, brace, or strap over tibial tuberosity
  • 90% respond well to conservative treatment
  • chronic, unresolved may need surgery
  • usually outgrow it
55
Q

Gout: overview

A
  • group of metabolic disorder
  • elevated serum uric acid, urate crystals in joints soft tissue and kidneys
56
Q

Gout risk factors

A
  • family history
  • age & increasing serum urate concentration
  • heavy alcohol consumption, obesity, HTN
  • hyperthriodism, renal insufficiency, Chemo pts
57
Q

pathogenesis: Gout

A
  1. Primary hyperuricemia: inherited disorder of uric acid metabolism
  2. Secondary Hyperuricemia: caused from other metabolic disorders, decreased renal fuction, neoplasm
  3. idopathic hyperuricemia
58
Q

clinical manifestations: gout

A
  • Asymptomatic hyperuricemia
  • acute gouty arthritis (most common, increase pain in 1 joint) redness, swelling, warmth
  • intercritical gout: next phase- asymptomatic but still hyperuricemia (months/yrs)
  • Chronic Tophaceous gout: return of symptoms, deposits of crystals in soft tissues
59
Q

gout management

A
  • great imitator: imitates other things
  • DD: septic arthritis, RA, neoplasm, triad of acute arthritis, hyperuricemia, response to meds allopurinol
  • presence of monosodium urate crystals in synovial fluid, CT, or other articular cartilage
60
Q
  1. osteomalacia
  2. osteopenia
  3. osteopetrosis
  4. osteoporosis
A
  1. softening of bone
  2. low bone mass
  3. increased bone density
  4. decreased bone density
61
Q

Osteoporosis: overview

A
  • most commone metabolic bone disorder
  • low bone mass/impaired bone quality
  • increased risk of skeletal deformity
  • increased of fracture
  • primary vs secondary
  • typically affects vertebral bodies
62
Q

Osteoporosis: diagnosis

A
  • history
  • medical imaging
  • bone mineral density testing
  • dual x-ray absorptiometry assessment DXA
  • radiographs or CT if suspected fracture
  • lab tests
63
Q

Osteoporosis: clinical manifestations

A
  • Posture: thoracic kyphosis, forward head, protuberant abdomen, posterior pelvic tilt, IR of shoulders, scapular protrusion, knee hyperextension
  • loss of height
  • change in facial appearance
  • muscle imbalance, muscle pain, and trigger points
64
Q

Osteoporosis: pathogenesis

A
  • strength depends on density and quality
  • BMD is measure of mass or minerals/volume of bone
  • quality depends on cells, matrix and minerals
65
Q

Osteoporosis: Risk factors

A
  • Nonmodifiable: age, ethnicity, family history, lactose intolerance
  • modifiable: exercise, tobacoo, caffeine, low body weight, diet, depression
66
Q

Commone meds associated with Osteoporosis:

A
  • corticosteriods
  • methotrexate
  • heparin/coumadin (blood thinners)
  • lasix (diuretic)
  • Depo-Provera
67
Q

Commone fracture sites with Osteoporosis:

A
  • vertebral compression fractures
  • hips
  • ribs
  • radius (fall)
  • femur
68
Q

treatment and prevention of Osteoporosis:
- diet

A
  • calcium/vitamin D
  • Eat more plants
69
Q

treatment and prevention of Osteoporosis:
- exercise

A
  • weightbearing
  • resistance
  • balance
  • whole body vibration
70
Q

treatment and prevention of Osteoporosis:
education

A
  • fall risk
71
Q

treatment and prevention of Osteoporosis: corrective surgery

A
  • kyphoplasty
  • vertebroplasty
72
Q

treatment and prevention of Osteoporosis:
medications bisphophonates

A
  • IV Aredia, zoledronate
  • Oral: risedronate; ibandronate, etidronate, alendronate, tiludronate
  • oral/IV: clodronic acid
73
Q

treatment and prevention of Osteoporosis:
medications other

A
  • hormonal therapy (ERT/HRT for women, testosterone for men)
  • estrogen agonist/antagonist: raloxifene/evista
  • calcitonin: nasal or injected
  • Parathryoid hormone
  • osteoprotegerin: decoy TNF receptor that prevents the enzymes that stimulate oasteoclast activity
74
Q

Pagets: overview

A
  • tends to occur in adults over 50
  • 2nd most common metabolic bone disease
  • bones will bow out and soft will be distorted
75
Q

Pagets: pathogenesis

A
  • increased osteoclast activity
  • osteoblasts cannot keep up
  • results: fibrotic bon, bone changes shape
76
Q

Pagets: clinical manifestations

A
  • insidious and slow progression
  • pain, skeletal, neurological, muscular, cardovascular
  • fatigue
  • tinnitus: ringing - bones in ear are affected
  • lightheaded, dizzy